![Inge Lues](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Inge Lues worked as Vice President-Global Drug Discovery at Merck KGaA in 2007.
From 2008 to 2018, Lues worked at Vivoryon Therapeutics NV, where she held the position of Chief Development Officer from 2013 to 2018.
Anciens postes connus de Inge Lues
| Sociétés | Poste | Fin |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Directeur Technique/Scientifique/R&D | 31/10/2018 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2007 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
